ALEC - Alector, Inc.
2.16
0.110 5.093%
Share volume: 437,289
Last Updated: 05-12-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.21%
PREVIOUS CLOSE
CHG
CHG%
$2.05
0.11
0.05%
Summary score
35%
Profitability
35%
Dept financing
41%
Liquidity
50%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 2022 - 2026
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-6.93%
Return on sales
-591.98%
Return on invested capital
0%
Total debt ratio
78.22%
Debt ratio change over timeo
0%
Current Ratio
4.31%
Quick Ratio
0%
Cash Position Ratio
0.83%
Short-term ratios 2025 - 2026
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-10.28%
Return on sales
-1150.97%
Return on invested capital
0%
Total debt ratio
87.01%
Debt ratio change over timeo
0%
Current Ratio
4.16%
Quick Ratio
0%
Cash Position Ratio
1.08%
Last quarter ratios 2026
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-9.56%
Return on sales
-2382.31%
Return on invested capital
0%
Total debt ratio
95.67%
Debt ratio change over time
0%
Current Ratio
5.25%
Quick Ratio
0%
Cash Position Ratio
1.88%
Performance ratios (change over 4 years) 2022 - 2026
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ALEC | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 6.81% | 8.91% |
| Return on assets | -6.93% | 2.84% | 3.37% | 2.03% |
| Return on sales | -591.98% | 25.8% | 27.39% | 21.58% |
| Return on invested capital | 0% | 0% | 4% | 10.25% |
| Profitability | 0% | 45% | 79% | 85% |
| Total debt ratio | 78.22% | 92.41% | 65.12% | 42.64% |
| Debt ratio change over time | 0% | 0% | 201.57% | 3.74% |
| Dept financing | 21% | 25% | 43% | 12% |
| Current Ratio | 4.16% | 1.25% | 1.57% | 2.74% |
| Quick Ratio | 0% | 0.97% | 1.41% | 2.07% |
| Cash Position Ratio | 1.08% | 0.42% | 0.63% | 1.02% |
| Liquididy | 50% | 53% | 42% | 60% |
| Short-term ratios | ALEC | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -10.28% | 3.26% | 5.11% | 1.41% |
| Return on sales | -1150.97% | 28.47% | 34.99% | 15.72% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 36% | 50% | 18% |
| Total debt ratio | 87.01% | 90.35% | 61.91% | 37.54% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 49% | 25% | 17% | 10% |
| Current Ratio | 4.16% | 1.25% | 1.57% | 2.74% |
| Quick Ratio | 0% | 0.97% | 1.41% | 2.07% |
| Cash Position Ratio | 1.08% | 0.42% | 0.63% | 1.02% |
| Liquididy | 50% | 29% | 41% | 65% |